112 related articles for article (PubMed ID: 2428478)
1. Elevated levels of a high molecular weight antigen detected by antibody W1 in sera from breast cancer patients.
Linsley PS; Ochs V; Laska S; Horn D; Ring DB; Frankel AE; Brown JP
Cancer Res; 1986 Oct; 46(10):5444-50. PubMed ID: 2428478
[TBL] [Abstract][Full Text] [Related]
2. Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker.
Bray KR; Koda JE; Gaur PK
Cancer Res; 1987 Nov; 47(22):5853-60. PubMed ID: 2444335
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies reactive with mucin glycoproteins found in sera from breast cancer patients.
Linsley PS; Brown JP; Magnani JL; Horn D
Cancer Res; 1988 Apr; 48(8):2138-48. PubMed ID: 2450646
[TBL] [Abstract][Full Text] [Related]
4. Detection of mammary serum antigen in sera from breast cancer patients using monoclonal antibody 3E1.2.
Stacker SA; Thompson CH; Sacks NP; Tjandra J; Lowe MG; Bishop J; McKenzie IF
Cancer Res; 1988 Dec; 48(24 Pt 1):7060-6. PubMed ID: 3191482
[TBL] [Abstract][Full Text] [Related]
5. Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer.
Iacobelli S; ArnĂ² E; D'Orazio A; Coletti G
Cancer Res; 1986 Jun; 46(6):3005-10. PubMed ID: 3516389
[TBL] [Abstract][Full Text] [Related]
6. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing epitopes consisting of sialyl or sialyl-fucosyl type 1 chain.
Kannagi R; Kitahara A; Itai S; Zenita K; Shigeta K; Tachikawa T; Noda A; Hirano H; Abe M; Shin S
Cancer Res; 1988 Jul; 48(13):3856-63. PubMed ID: 2454154
[TBL] [Abstract][Full Text] [Related]
7. Detection of a breast tissue-associated antigen by antiserum to Raji cell-bound circulating immune complexes of human breast cancer.
Koestler TP; Papsidero LD; Nemoto T; Chu TM
Cancer Res; 1981 Jul; 41(7):2900-7. PubMed ID: 7018673
[TBL] [Abstract][Full Text] [Related]
8. Expression of ductal carcinoma antigen in breast cancer sera as defined using monoclonal antibody F36/22.
Papsidero LD; Nemoto T; Croghan GA; Chu TM
Cancer Res; 1984 Oct; 44(10):4653-7. PubMed ID: 6088042
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of elevated anti-Lewis antibodies in sera of cancer patients using a carcinoembryonic antigen-polyethylene glycol immunoassay.
Pompecki R; Shively JE; Todd CW
Cancer Res; 1981 May; 41(5):1910-5. PubMed ID: 6163531
[TBL] [Abstract][Full Text] [Related]
10. Heritable variation in expression of multiple tumor associated epitopes on a high molecular weight mucin-like antigen.
Linsley PS; Ochs V; Horn D; Ring DB; Frankel AE
Cancer Res; 1986 Dec; 46(12 Pt 1):6380-6. PubMed ID: 2430697
[TBL] [Abstract][Full Text] [Related]
11. MAM-6 antigen, a new serum marker for breast cancer monitoring.
Hilkens J; Kroezen V; Bonfrer JM; De Jong-Bakker M; Bruning PF
Cancer Res; 1986 May; 46(5):2582-7. PubMed ID: 3697998
[TBL] [Abstract][Full Text] [Related]
12. Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer.
Allard WJ; Neaman IE; Elting JJ; Barnett TR; Yoshimura H; Fritsche HA; Yeung KK
Cancer Res; 1994 Mar; 54(5):1227-34. PubMed ID: 8118811
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and immunochemical analysis of a breast carcinoma associated antigen defined by the monoclonal antibody NCRC-11.
Price MR
Arch Geschwulstforsch; 1987; 57(3):177-80. PubMed ID: 2441681
[TBL] [Abstract][Full Text] [Related]
15. [CA 15-3 is present as a novel tumor marker in the sera of patients with breast cancer and other malignancies].
Gang Y; Adachi I; Ohkura H; Yamamoto H; Mizuguchi Y; Abe K
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2379-86. PubMed ID: 3865634
[TBL] [Abstract][Full Text] [Related]
16. MCA performance in preoperative breast cancer patients.
Donadeo A; Micelli G; Quaranta M; Atlante A; Schittulli F
Anticancer Res; 1995; 15(2):527-9. PubMed ID: 7763034
[TBL] [Abstract][Full Text] [Related]
17. Mammary serum antigen (MSA) levels as a marker for breast cancer: a survey of blood donors and patients with cancer.
Stacker SA; Thompson CH; Lowe MG; Sacks NP; Golder J; Carmen H; McKenzie IF
Dev Biol Stand; 1987; 67():91-6. PubMed ID: 3609486
[TBL] [Abstract][Full Text] [Related]
18. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas.
Friedman EL; Hayes DF; Kufe DW
Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435
[TBL] [Abstract][Full Text] [Related]
19. [Levels of circulating tumor-associated glycoprotein (TAG-72) in patients with carcinoma using a novel tumor marker, CA 72-4].
Ohuchi N; Matoba N; Taira Y; Takahashi K; Sakai N; Sato K; Fujita N; Mochizuki F; Nishihira T; Mori S
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2767-72. PubMed ID: 3166366
[TBL] [Abstract][Full Text] [Related]
20. A human breast tissue-associated antigen detected by a monoclonal antibody.
Thompson CH; Jones SL; Whitehead RH; McKenzie IF
J Natl Cancer Inst; 1983 Mar; 70(3):409-19. PubMed ID: 6187962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]